However, the cytotoxic effect was dramatically decreased by combining IL-27 treatment with either cytarabine or daunorubicin compared with the drug alone, and IL-27 revealed greater antichemotherapeutic effect in the erythroleukemic cell lines than in the AML cell line (Fig. 2D). Here, IL27 is linked to acute myeloid leukemia.